8.1 C
2.1 C
20.3 C
0.9 C
12.3 C
New York
18.2 C
Sunday, April 11, 2021

The “Unknown” Humble Couple Behind the Pfizer Vaccine. Children of Turkish Immigrants, Billionaires and Aspiring “Saviors” of Humanity.


Highly encouraging evidence of the effectiveness of the BioNTech vaccine and its American partner, Pfizer, in the treatment of coronavirus is an unexpected success for the married couple behind the German biotechnology company, who have dedicated their lives to shield the immune system from cancer.

Pfizer and BioNTech are the first pharmaceutical companies in the West to successfully present data from a large-scale clinical trial of a coronavirus vaccine. The two companies said they have so far found no serious safety concerns and are expected to apply for an emergency permit from the US later this month.

Having humble roots as the son of a Turkish immigrant working at a Ford plant in Cologne, BioNTech CEO Ugur Sahin, 55, is now one of the 100 richest Germans, along with his wife and fellow colleague Eio Toureci, 53, according to the weekly Welt am Sonntag.

Greece: The Germans Set Up a Giant Business With the Coronavirus Vaccine

The market value of the Nasdaq BioNTech listed company, which the couple co-founded, had reached $21 billion at the close of trading last Friday from $4.6 billion a year ago, with the company playing a significant role in mass immunization / vaccination against coronavirus.

“Despite his achievements, he has never changed from being incredibly humble and cheerful,” said Matthias Cromayer, a board member of venture capital firm MIG AG, whose funds have supported BioNTech since its inception in 2008.

He added that Sahin usually goes to business meetings wearing jeans and brings with him his bicycle helmet and a backpack.

Sahin worked hard on his childhood dream of studying medicine and becoming a doctor, working at university hospitals in Cologne and the southwestern city of Homburg, where he met Tureci in the early stages of his academic career.

Unrepentant is the teacher at the Lyceum of Ymittos who asked for mascara instead of ... mask: "I want to be judged"

Medical research and oncology became their common passion.

Tureci, the daughter of a Turkish doctor who had immigrated to Germany, told the media that even on their wedding day, they both spent time working in the laboratory.

Together they focused on the immune system as a potential ally in the fight against cancer and tried to tackle the unique genetic makeup of each tumor.

They started their business in 2001 when they founded Ganymed Pharmaceuticals to develop antibodies to cancer, but Sahin – by that time he was a professor at the University of Mainz – never gave up academic research and teaching.

They won funding from MIG AG, as well as Thomas and Andreas Stringman, who sold the over-the-counter drug company Hexal to Novartis in 2005.

Study Published by Oxford Academic: Common Cold Blocks SARS-CoV-2 Replication Within Respiratory Tissue Lining

Their business was sold to Japanese Astellas in 2016 for $1.4 billion. Meanwhile, the team behind Ganymed, was already busy setting up BioNTech, which was founded in 2008 to look for a much wider range of cancer immunotherapy tools.

This included Messenger RNA (or mRNA), a flexible Messenger substance that sends genetic instructions to cells.

“Dream – Team”

For MIG’s Kromayer, Toureci and Sahin are a “dream” team, as they have “reconciled” their visions with the limitations of reality.

BioNTech’s story was about to change when Sahin stumbled upon a scientific study in January of a new coronavirus outbreak in the Chinese city of Wuhan and was struck by how small the step was from mRNA anticancer drugs to mRNA-based viral vaccines.

BioNTech quickly commissioned about 500 employees to work at “speed of light” on various possible chemical compounds and combinations, convincing pharmaceutical giant Pfizer and Chinese Fosun to partner with BioNTech in March.

Coronovirus: The implementation of the new measures has started - Traffic ban from 12:30 after midnight

Matthias Theobald, an associate professor of oncology at the University of Mainz who has worked with Sahin for 20 years, said his austerity stance did not go hand in hand with his unwavering ambition to transform medicine, as evidenced by his strong belief in a vaccine against COVID-19.

“He is a very modest and humble man. Appearance does not matter to him. “But he wants to create the structures that will allow him to realize his visions and that is where his ambitions are far from moderate,” according to Theobald.

Facebook Comments Box


Cuba: Interferon Alfa-2b Works in Treating Covid-19 in China

Nobelist who Discovered AIDS Dr. Luc Montangier Joins Israel Supreme Court Petition to Halt Covid-19 Vaccine Campaign

A petition yesterday was submitted to Israel’s Supreme Court by Nakim.org founders Dr. Hervé Seligmann and Haim Yativ seeking to halt the COVID-19 vaccine campaign. The article is available in Greek language here. They attached to the petition an opinion by Nobel Prize in Medicine laureate Prof. Luc Montagnier who discovered the AIDS virus. Prof. Montagnier approached Seligman and Yativ following...
A Study published by Oxford Academic for the Infectious Diseases Society of America finds that human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory tissue lining, presenting implications for Covid-19 epidemiology that lockdowns are likely to make infections worse. You can read this article in Greek language here. The researchers found that human rhinovirus triggers an innate immune response that blocks...
The article is available in Greek language here.Last December, the world’s leading vaccine experts met in Geneva and acknowledged that vaccine confidence was in the toilet. Despite the public health establishment’s best efforts to mock and dissipate “vaccine hesitancy,” these experts, convened by the World Health Organization (WHO), confessed that the number of citizens and health professionals raising questions...
Coronovirus: The implementation of the new measures has started - Traffic ban from 12:30 after midnight

Cuba: Interferon Alfa-2b Works in Treating Covid-19 in China

Some of the medication used for COVID-19 is a in particular promising Cuban compound referred to as "Interferon alfa-2b," which has been effectively administered to Chinese language sufferers. In Greece Dr. S Tsiodras the Infectious Disease Specialist by the Greek Government have made request for clinical trials of Interferon since April of 2020 however not anything carried out afterwards and...
Austria, Vienna Court: “PCR tests have no diagnostic value” The article is available in Greek language here. In Europe there is growing intolerance for anti-Covid tests and rules. The controversy comes directly from the administrative court in Vienna and concerns the "tampon" policy regarding the pandemic in Austria. A ruling of March 24, 2021, questions the use of test PCR, considering...

Follow Us on Social Media

Happening Now

Facebook Comments Box